scispace - formally typeset
Open AccessJournal ArticleDOI

Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea

Reads0
Chats0
TLDR
In this paper, the authors used high-density Roche 454 pyrosequencing to survey the distal gut microbiota for 39 individuals with CDI, 36 subjects with C. difficile-negative nosocomial diarrhea (CDN), and 40 healthy control subjects.
Abstract
Clostridium difficile infection (CDI) causes nearly half a million cases of diarrhea and colitis in the United States each year. Although the importance of the gut microbiota in C. difficile pathogenesis is well recognized, components of the human gut flora critical for colonization resistance are not known. Culture-independent high-density Roche 454 pyrosequencing was used to survey the distal gut microbiota for 39 individuals with CDI, 36 subjects with C. difficile-negative nosocomial diarrhea (CDN), and 40 healthy control subjects. A total of 526,071 partial 16S rRNA sequence reads of the V1 to V3 regions were aligned with 16S databases, identifying 3,531 bacterial phylotypes from 115 fecal samples. Genomic analysis revealed significant alterations of organism lineages in both the CDI and CDN groups, which were accompanied by marked decreases in microbial diversity and species richness driven primarily by a paucity of phylotypes within the Firmicutes phylum. Normally abundant gut commensal organisms, including the Ruminococcaceae and Lachnospiraceae families and butyrate-producing C2 to C4 anaerobic fermenters, were significantly depleted in the CDI and CDN groups. These data demonstrate associations between the depletion of Ruminococcaceae, Lachnospiraceae, and butyrogenic bacteria in the gut microbiota and nosocomial diarrhea, including C. difficile infection. Mechanistic studies focusing on the functional roles of these organisms in diarrheal diseases and resistance against C. difficile colonization are warranted.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Comparison of the fecal bacterial microbiota of healthy and diarrheic foals at two and four weeks of life

TL;DR: Preventative and therapeutic measures for diarrhea should focus on maintaining bacterial microbiota richness, and Lachnospiraceae and Ruminococcaceae were underrepresented in foals with diarrhea.
Journal ArticleDOI

Dual role of microbiota-derived short-chain fatty acids on host and pathogen

TL;DR: A growing body of documents shows microbiota produce metabolites such as short-chain fatty acids (SCFAs) as crucial executors of diet-based microbial influence the host and bacterial pathogens as discussed by the authors .
Journal ArticleDOI

Dual role of microbiota-derived short-chain fatty acids on host and pathogen.

TL;DR: A growing body of documents shows microbiota produce metabolites such as short-chain fatty acids (SCFAs) as crucial executors of diet-based microbial influence the host and bacterial pathogens as mentioned in this paper.
Journal ArticleDOI

Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home.

TL;DR: A high C. difficile colonisation in nursing home residents was found, with a predominance of the hypervirulent PCR-ribotype 027, and positive C. Difficile status is not associated with microbiota richness or biodiversity reduction in this study.
Journal ArticleDOI

The promise of the gut microbiome as part of individualized treatment strategies

TL;DR: In this article, the authors discuss six broad disease groups: infectious disease, cancer, metabolic disease, cardiovascular disease, autoimmune or inflammatory disease, and allergic and atopic diseases and highlight current knowledge on the gut microbiome in disease pathogenesis and prognosis, efficacy, and treatment-related adverse events.
References
More filters
Journal ArticleDOI

Metagenomic biomarker discovery and explanation

TL;DR: A new method for metagenomic biomarker discovery is described and validates by way of class comparison, tests of biological consistency and effect size estimation to address the challenge of finding organisms, genes, or pathways that consistently explain the differences between two or more microbial communities.
Journal ArticleDOI

SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB

TL;DR: SILVA (from Latin silva, forest), was implemented to provide a central comprehensive web resource for up to date, quality controlled databases of aligned rRNA sequences from the Bacteria, Archaea and Eukarya domains.
Journal ArticleDOI

The human microbiome project.

TL;DR: A strategy to understand the microbial components of the human genetic and metabolic landscape and how they contribute to normal physiology and predisposition to disease.
Journal ArticleDOI

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

TL;DR: The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin and patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.
Related Papers (5)